Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
I know, that buy dildos online is cheaper.
Popular Articles

Florida-Based Organization Encourages Black Women To Be Tested For HIV
The one-year-old Florida-based organization Sistas Organizing to Survive on Saturday held a rally in Orlando that sought to raise awareness of HIV among black women and encourage them to be tested, the Orlando Sentinel reports. According to Debbie Tucci, coordinator for the Orange County Health Department"s HIV/AIDS program, one in 68 black women in the state is living with HIV/AIDS and many are unaware they are infected. AIDS has been a leading cause of death for black women ages 25 to 44 in the state for the past 15 years, the Sentinel reports (Ruano Gonzç¡lez, Orlando Sentinel, 6/21).
drugs without prescription
Filling The Gap Between The ER And The Family Doctor: Urgent Care Centers
Urgent care centers (UCCs) are providing an alternative to emergency room treatment. A study published in the open access journal BMC Health Services Research has shown that UCCs tend to be open well outside of office hours and offer a wider range of services than primary care offices.
News of the day
China Aoxing Pharmaceutical Company Announces Completion Of Registration Trial Of Its Leading Narcotic Drug For The Treatment Of Cough
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, announced that it has completed the registration trial with Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough. Top-line results from this trial are expected to be announced by the end of the third quarter of 2009.
Health Insurance

New Treatment Option In The Fight Against Prostate Cancer - Implant Gives Men Flexibility In Treatment Choices

A new 12 month hormone therapy treatment is launched for men with advanced prostate cancer. The Vantas® (histrelin) implant is a small and flexible device, made from the same materials as soft contact lenses. Vantas® is the first 12 month implant to treat prostate cancer to be available in the UK.1 The Vantas® implant is unique in that it is placed under the skin in the upper arm and releases luteinising hormone-releasing hormone (LHRH) over a continuous 12 month period, and is an alternative treatment option to other available LHRH therapies which are currently available as treatments given every one or three months.1,2 The aim is to provide a convenient option for men who wish to continue with their lives as normally as possible with minimum disruption caused by their prostate cancer treatment. Mr John Anderson, Consultant Urologist at Royal Hallamshire Hospital, Sheffield said: "Vantas® represents a milestone in terms of opening up treatment choice for men with advanced prostate cancer - that is metastatic, late stage and locally advanced types of the disease. Metastatic cancer accounts for 20 - 30% of men diagnosed with prostate cancer.3 The Vantas® implant is simple and quick to insert2 and means these men can continue to live life, work and travel without the need for more regular injections - although it is of course still important that they keep to scheduled check-up appointments." Mr Anderson continued: "Vantas® is also unique in that the implant can be quickly removed, which is important if side effects need to be quickly stopped.2 The side effects of LHRH hormone therapies such as Vantas® include hot flushes, impotence or decreased libido.1" Rebecca Porta of the male cancer charity Orchid said, "Around 35,000 men are diagnosed with prostate cancer in the UK each year4 and over 10,000 will die from it.5 We welcome new treatment options that doctors can discuss with patients and their families, especially those which can offer patients an improved quality of life." Most men with advanced prostate cancer are recommended to have hormonal therapy6 and one of the options recommended by the National Institute for Health and Clinical Excellence is the use of LHRH agonists7, synthetic versions of the normal hormone released by humans. Vantas® is a LHRH agonist which means it inhibits the production of testosterone in the body, therefore slowing the growth of prostate cancer cells. References 1- Vantas Summary of Product Characteristics, October 2007 2- Crawford DC, A review of the use of histrelin in the treatment of prostate cancer, manuscript 2008 3- http://www.cancerhelp.org.uk/help/default.asp?page=3505 (last accessed June 2009) 4- htthttp://www.prostatecancermatters.org.uk/faq.asp (last accessed June 2009) 5- http://info.cancerresearchuk.org/cancerstats/types/prostate/ (last accessed June 2009) 6- Click here (last accessed June 2009) 7- National Institute for Health and Clinical Excellence, Prostate Cancer - Diagnosis and treatment. February 2008 http://www.nice.org.uk/nicemedia/pdf/CG58FullGuideline.pdf Orion


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009